CRISTINA BOCCALANDRO
Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism HOUSTON, TX NPI 1508890427
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism TX Radius Health, Inc. All categories
General Payments — all program years on this page
$22,370.98
- Category: General Payments
- Program years: PY2018–2024
- Record count: 1,065
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $2,057.98 across 113 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,975.28 | 111 |
| Education | $82.70 | 2 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Radius Health, Inc. | $232.58 | 19 |
| Lilly USA, LLC | $183.34 | 11 |
| Amgen Inc. | $179.97 | 11 |
| Abbott Laboratories | $170.72 | 10 |
| Novo Nordisk AS | $144.68 | 7 |
| Tandem Diabetes Care, Inc. | $135.53 | 5 |
| Astellas Pharma US Inc | $126.46 | 3 |
| Amneal Pharmaceuticals LLC | $101.20 | 6 |
| Antares Pharma, Inc. | $99.36 | 5 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $90.41 | 6 |
| IBSA Pharma Inc. | $87.52 | 5 |
| SANOFI-AVENTIS U.S. LLC | $64.83 | 3 |
| MannKind Corporation | $55.15 | 3 |
| DEXCOM, INC. | $52.76 | 3 |
| BETA BIONICS, INC. | $51.49 | 3 |
| Bayer HealthCare Pharmaceuticals Inc. | $49.03 | 3 |
| Medtronic, Inc. | $48.47 | 1 |
| Acerta Pharma LLC | $45.79 | 2 |
| Esperion Therapeutics, Inc. | $34.88 | 2 |
| Currax Pharmaceuticals LLC | $33.14 | 2 |
| Acella Pharmaceuticals, LLC | $27.25 | 1 |
| Corcept Therapeutics | $24.95 | 1 |
| CeQur Corporation | $18.47 | 1 |
By program year
Records — PY2024 (113)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.